GENEVA, June 19 -- OBSIDIAN THERAPEUTICS, INC. (1030 Massachusetts Avenue4th FloorCambridge, Massachusetts 02138) filed a patent application (PCT/US2024/058989) for "COMPOSITIONS AND METHODS FOR ENHANCED PAYLOAD REGULATION USING NUCLEAR FACTOR OF ACTIVATED T CELLS (NFAT) RESPONSE ELEMENTS" on Dec 06, 2024. With publication no. WO/2025/122943, the details related to the patent application was published on Jun 12, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TER MEULEN, Jan (c/o Obsidian Therapeutics, Inc.1030 Massachusetts Avenue4th FloorCambridge, Massachusetts 02138), SETHI, Dhruv (c/o O...